Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Intra medullary endo-transilluminating device (iMET device)

K-Number: K163037 · 2017-02-17

Decision Date2017-02-17
Product CodeHRX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Intra medullary endo-transilluminating device (iMET device) is a medical device manufactured by WeMED Bio-Tech, Inc.. It received FDA 510(k) clearance on 2017-02-17 under approval number K163037. The device is classified under product code HRX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Intra medullary endo-transilluminating device (iMET device)?

Intra medullary endo-transilluminating device (iMET device) is a medical device that received FDA 510(k) clearance on 2017-02-17. It is manufactured by WeMED Bio-Tech, Inc.. The 510(k) number is K163037.

When was Intra medullary endo-transilluminating device (iMET device) approved by the FDA?

Intra medullary endo-transilluminating device (iMET device) received FDA 510(k) clearance on 2017-02-17, under approval number K163037.

What company makes Intra medullary endo-transilluminating device (iMET device)?

Intra medullary endo-transilluminating device (iMET device) is manufactured by WeMED Bio-Tech, Inc..

What is the FDA product code for Intra medullary endo-transilluminating device (iMET device)?

The FDA product code for Intra medullary endo-transilluminating device (iMET device) is HRX.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: HRX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.